AAAAAA
Results:
1-17
|
Results: 17
Authors:
KERSCHAN K
PANKL W
AUFF E
Citation: K. Kerschan et al., SPEECH DISORDERS IN PATIENTS WITH PARKINS ONS-DISEASE, Wiener Klinische Wochenschrift, 110(8), 1998, pp. 279-286
Authors:
WENZEL T
SCHNIDER P
WIMMER A
STEINHOFF N
MORARU E
AUFF E
Citation: T. Wenzel et al., PSYCHIATRIC COMORBIDITY IN PATIENTS WITH SPASMODIC TORTICOLLIS, Journal of psychosomatic research, 44(6), 1998, pp. 687-690
Authors:
FERTL E
STEINHOFF N
SCHOFL R
POTZI R
DOPPELBAUER A
MULLER C
AUFF E
Citation: E. Fertl et al., TRANSIENT AND LONG-TERM FEEDING BY MEANS OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN NEUROLOGICAL REHABILITATION, European neurology, 40(1), 1998, pp. 27-30
Authors:
FERTL E
SCHNIDER P
MULLER C
AUFF E
Citation: E. Fertl et al., PERSISTENT AMNESIC SYNDROME AS LONG-TERM OUTCOME OF COGNITIVE FUNCTION AFTER WHIPPLES-DISEASE, European journal of neurology, 4(6), 1997, pp. 613-617
Authors:
BERGER T
MALAYERI R
DOPPELBAUER A
KRAJNIK G
HUBER H
AUFF E
PIRKER R
Citation: T. Berger et al., NEUROLOGICAL MONITORING OF NEUROTOXICITY INDUCED BY PACLITAXEL CISPLATIN CHEMOTHERAPY/, European journal of cancer, 33(9), 1997, pp. 1393-1399
Authors:
SCHNIDER PJ
REISINGER EC
BERGER T
KREJS GJ
AUFF E
Citation: Pj. Schnider et al., TREATMENT GUIDELINES IN CENTRAL-NERVOUS-SYSTEM WHIPPLES-DISEASE, Annals of neurology, 41(4), 1997, pp. 561-562
Authors:
SCHNIDER P
GRUNBERGER J
SCHMIED M
VASS K
LINZMAYER L
AUFF E
Citation: P. Schnider et al., PUPILLOMETRY AFTER BOTULINUM-A TOXIN TREATMENT, Neuro-ophthalmology, 17(1), 1997, pp. 5-9
Authors:
SCHNIDER P
BINDER M
KITTLER H
STEINHOFF N
AUFF E
Citation: P. Schnider et al., USES OF BOTULINUM TOXIN, Lancet, 349(9056), 1997, pp. 953-953
Authors:
BAAS H
BEISKE AG
GHIKA J
JACKSON M
OERTEL WH
POEWE W
RANSMAYR G
AUFF E
VOLC D
DUPONT E
MIKKELSEN B
WERMUTH L
WOMMPETERSEN J
BENECKE R
EICHHOM T
KOLBE H
OERTEL W
SCHIMRIGK K
OLSSON JE
PALHAGEN S
BURGUNDER JM
GHIKA A
REGLI F
STECK A
MEDCALF P
Citation: H. Baas et al., CATECHOL-O-METHYLTRANSFERASE INHIBITION WITH TOLCAPONE REDUCES THE WEARING OFF PHENOMENON AND LEVODOPA REQUIREMENTS IN FLUCTUATING PARKINSONIAN-PATIENTS, Journal of Neurology, Neurosurgery and Psychiatry, 63(4), 1997, pp. 421-428
Authors:
SCHNIDER P
BINDER M
AUFF E
KITTLER H
BERGER T
WOLFF K
Citation: P. Schnider et al., DOUBLE-BLIND TRIAL OF BOTULINUM-A TOXIN FOR THE TREATMENT OF FOCAL HYPERHIDROSIS OF THE PALMS, British journal of dermatology, 136(4), 1997, pp. 548-552
Authors:
SCHNIDER PJ
REISINGER EC
GERSCHLAGER W
MULLER C
BERGER T
KREJS GJ
AUFF E
Citation: Pj. Schnider et al., LONG-TERM FOLLOW-UP IN CEREBRAL WHIPPLES-DISEASE, European journal of gastroenterology & hepatology, 8(9), 1996, pp. 899-903
Authors:
SCHNIDER P
TRATTNIG S
KOLLEGGER H
AUFF E
Citation: P. Schnider et al., MR OF CEREBRAL WHIPPLE DISEASE, American journal of neuroradiology, 16(6), 1995, pp. 1328-1329
Authors:
SCHNIDER P
BERGER T
SCHMIED M
FERTL L
AUFF E
Citation: P. Schnider et al., INCREASED RESIDUAL URINE AFTER BOTULINUM- A-TOXIN TREATMENT, Nervenarzt, 66(6), 1995, pp. 465-467
Authors:
MULLER C
WENGER S
FERTL L
AUFF E
Citation: C. Muller et al., INITIATION OF VISUAL-GUIDED RANDOM SACCADES AND REMEMBERED SACCADES IN PARKINSONIAN-PATIENTS WITH SEVERE MOTOR-FLUCTUATIONS, Journal of neural transmission. Parkinson's disease and dementia section, 7(2), 1994, pp. 101-108
Authors:
SCHNIDER P
SCHMIED M
BERGER T
AUFF E
Citation: P. Schnider et al., THERAPEUTIC USE OF BOTULINUM-A TOXIN IN N EUROLOGICAL DISORDERS, Wiener Klinische Wochenschrift, 106(11), 1994, pp. 335-344
Authors:
FERTL E
DOPPELBAUER A
AUFF E
Citation: E. Fertl et al., PHYSICAL-ACTIVITY AND SPORTS IN PATIENTS SUFFERING FROM PARKINSONS-DISEASE IN COMPARISON WITH HEALTHY SENIORS, Journal of neural transmission. Parkinson's disease and dementia section, 5(2), 1993, pp. 157-161
Authors:
SCHNIDER P
BRICHTA A
SCHMIED M
AUFF E
Citation: P. Schnider et al., GALLBLADDER DYSFUNCTION INDUCED BY BOTULINUM-A TOXIN, Lancet, 342(8874), 1993, pp. 811-812
Risultati:
1-17
|